MedPath

Effects of Interpersonal Psychotherapy for depressed adolescents (IPT-A) in an outpatient therapy setting

Not Applicable
Conditions
F32.0
F33.0
Mild depressive episode
Recurrent depressive disorder, current episode mild
Registration Number
DRKS00006554
Lead Sponsor
niversitätsklinikum Freiburg, Zentrum für psychische Erkrankungen Klinik für Psychiatrie, Psychotherapie und Psychosomatik im Kindes- und Jugendalter
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
18
Inclusion Criteria

ICD-10: F32 / F33.
Other inclusion criteria are : IQ = 85 and at least visit the secondary school as well as values ??for the questionnaires CDRS - R = 36 and the BDI - II = 14th

Exclusion Criteria

acute psychosis, drug abuse, acute suicidality, severe OCD, severe
Anxiety disorder, severe Tourette syndrome, severe eating disorders, social disorders and mental retardation, bipolar disorder, insufficient knowledge of the german language.
Medication is in principle not a criterion for exclusion, however, requires that the medication for 3 weeks is kept stable. Dyslexia is also not an exclusion criterion.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of Strength of depressive symptoms is measured by Children’s Depression Rating Scale – Revised (CDRS-R).<br><br>Data are collected each on three dates. Once before starting treatment, once after the end of therapy and again 6 months after cessation of treatment (catamnesis).
Secondary Outcome Measures
NameTimeMethod
Improvement of Functioning is measured by Global Assessment of Functioning (GAF). Changes of Psychopathology is measured by Clinical Global Impression Scale (CGI). Improvement of interpersonal problems is measured by Conflict Behavior Questionnaire (CBQ-20). Improvement of social functioning is measured by Social Adjustment Scale (SAS-SR).<br><br>Data are collected each on three dates. Once before starting treatment, once after the end of therapy and again 6 months after cessation of treatment (catamnesis).
© Copyright 2025. All Rights Reserved by MedPath